ACAMPROSATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Acamprosate, and when can generic versions of Acamprosate launch?
Acamprosate is a drug marketed by Appco, Barr Labs Div Teva, Bionpharma, Glenmark Pharms Ltd, Mylan, and Zydus Pharms. and is included in six NDAs.
The generic ingredient in ACAMPROSATE is acamprosate calcium. There are eight drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the acamprosate calcium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Acamprosate
A generic version of ACAMPROSATE was approved as acamprosate calcium by GLENMARK PHARMS LTD on July 16th, 2013.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ACAMPROSATE?
- What are the global sales for ACAMPROSATE?
- What is Average Wholesale Price for ACAMPROSATE?
Summary for ACAMPROSATE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| DailyMed Link: | ACAMPROSATE at DailyMed |
US Patents and Regulatory Information for ACAMPROSATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Appco | ACAMPROSATE CALCIUM | acamprosate calcium | TABLET, DELAYED RELEASE;ORAL | 218984-001 | Mar 16, 2026 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Glenmark Pharms Ltd | ACAMPROSATE CALCIUM | acamprosate calcium | TABLET, DELAYED RELEASE;ORAL | 202229-001 | Jul 16, 2013 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Barr Labs Div Teva | ACAMPROSATE CALCIUM | acamprosate calcium | TABLET, DELAYED RELEASE;ORAL | 200143-001 | Nov 18, 2013 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Bionpharma | ACAMPROSATE CALCIUM | acamprosate calcium | TABLET, DELAYED RELEASE;ORAL | 219904-001 | Sep 18, 2025 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
